A Product and Pipeline Analysis of the Global Haematology Therapeutics Market
A Product and Pipeline Analysis of the Global Haematology Therapeutics Market
An Overview of Promising Drugs and Innovations in the Haematology Therapeutics Market
RELEASE DATE
19-Mar-2013
19-Mar-2013
REGION
Europe
Europe
Research Code: 9837-00-5F-00-00
SKU: LS00243-EU-MR_17654
$1,500.00
In stock
SKU
LS00243-EU-MR_17654
Description
This market insight provides the list of key marketed products as well key compounds in phase 2 and 3 clinical trials in the global nonmalignant blood disorders market, classified into eight major segments including antianaemics, anticoagulants, antifibrinolytics, fibrinolytics, blood substitutes, plasma expanders, platelet aggregation inhibitors, and other haematologicals. Additionally, an overview of the major on-going phase 3 clinical trials and detailed findings of most promising phase 3 compounds have also been provided.
Table of Contents
Executive Summary
Introduction
Epidemiology
Competitive Landscape
Clinical Development Analysis
The Frost & Sullivan Story
Popular Topics
This market insight provides the list of key marketed products as well key compounds in phase 2 and 3 clinical trials in the global nonmalignant blood disorders market, classified into eight major segments including antianaemics, anticoagulants, antifibrinolytics, fibrinolytics, blood substitutes, plasma expanders, platelet aggregation inhibitors, and other haematologicals. Additionally, an overview of the major on-going phase 3 clinical trials and detailed findings of most promising phase 3 compounds have also been provided.
No Index | Yes |
---|---|
Podcast | No |
Author | Aiswariya Chidambaram |
WIP Number | 9837-00-5F-00-00 |
Is Prebook | No |